Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery 2023-12-11 09:00
Antengene Announces the Study of Anti-CD24 Monoclonal Antibody ATG-031 Dosed Its First Patient in the United States 2023-12-11 08:30
Dizal's Golidocitinib Pivotal Trial Demonstrates Superior and Durable Clinical Benefits for Patients with r/r PTCL in Oral Presentation at 2023 ASH 2023-12-10 18:00
PharmaBlock Officially Joins United Nations Global Compact 2023-12-08 12:37
CStone Announces NMPA Approval of Sugemalimab as First-line Treatment for Esophageal Squamous Cell Carcinoma 2023-12-08 12:10
CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms 2023-12-08 10:38
Regor Announces Promising Safety And Single Agent Efficacy Data Evaluating RGT-419B In HR+/HER2- Advanced Breast Cancer Patients Who Have Progressed On CDK4/6 Inhibitors And Endocrine Therapy 2023-12-08 07:39
2023 SABCS - TransThera announces an oral presentation of tinengotinib clinical data in breast cancer 2023-12-07 21:00
Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Study 2023-12-07 09:00
Positive Topline Results from Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer Presented at SABCS 2023-12-07 06:45
LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches 2023-12-06 23:00
GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant 2023-12-06 22:30
SaniSure earns EcoVadis Silver Rating, recognizing strong commitment to sustainability 2023-12-06 20:30
WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader 2023-12-06 17:00
Antengene Announces XPOVIO® Regulatory Approval in Macau for the Treatment of Relapsed and/or Refractory Multiple Myeloma 2023-12-06 17:00
Qilu Pharmaceutical Announces Results from Phase II Study for iparomlimab for Advanced Solid Tumors at ESMO Asia, with an ORR of 45.8% 2023-12-06 16:55
Koselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform neurofibromas 2023-12-06 16:46
Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma 2023-12-06 08:16
Results of three investigator-initiated trials on cadonilimab (PD-1/CTLA-4) for G/GEJC, pMMR/MSS mCRC, and HCC neoadjuvant therapy published at ESMO Asia 2023 2023-12-05 21:00
Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis 2023-12-05 21:00
1 62 63 64 65 66 413